Product Information
FEBUXOSTAT 80 MG TABLET is a generic product labeled by Hikma Pharmaceuticals USA Inc., priced at $0.3297 per EA under NDC 00054041413. Its NADAC has been published 342 times since Dec 11, 2019.
Strength
80 mg/1
Manufacturer
Hikma Pharmaceuticals USA Inc.NDC
00054041413
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
FEBUXOSTATApproval Type
Generic (ANDA)
FDA Application
ANDA205414On Market Since
11/11/2019
Pharmacological Classes
Price Statistics
The NADAC for FEBUXOSTAT 80 MG TABLET has been published 342 times since Dec 11, 2019, and over the history we have for it it has declined 93.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3297 per EA |
|---|---|
| All-time high | $5.3769 (Dec 11, 2019) |
| All-time low | $0.2636 (Feb 18, 2026) |
| 52-week high | $0.4893 |
| 52-week low | $0.2636 |
| Median price | $0.7024 |
| Average price | $1.0904 |
| Largest weekly change | +46.7% (Feb 22, 2023) |
| Weeks tracked | 342 |
| Tracking since | Dec 11, 2019 |
Generic Alternatives
The matcher finds 6 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 6 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of FEBUXOSTAT 80 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for FEBUXOSTAT 80 MG TABLET, manufactured by Hikma Pharmaceuticals USA Inc., is $0.3297 per EA (NDC 00054041413), effective Jun 24, 2026.
How has the price of FEBUXOSTAT 80 MG TABLET changed over time?
Over the history we have for it, the NADAC for FEBUXOSTAT 80 MG TABLET has declined 93.9%. It has been tracked across 342 weekly CMS publications since Dec 11, 2019.
What are the highest and lowest recorded NADAC prices for FEBUXOSTAT 80 MG TABLET?
Since Dec 11, 2019, the NADAC for FEBUXOSTAT 80 MG TABLET has ranged from a low of $0.2636 (Feb 18, 2026) to a high of $5.3769 (Dec 11, 2019), with a median of $0.7024 per EA.
Are there cheaper alternatives to FEBUXOSTAT 80 MG TABLET?
6 NADAC-published products share the same active ingredient, strength, and dosage form as FEBUXOSTAT 80 MG TABLET, but none are currently priced below it.
Who manufactures FEBUXOSTAT 80 MG TABLET?
FEBUXOSTAT 80 MG TABLET (NDC 00054041413) is labeled by Hikma Pharmaceuticals USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification